Teckningsperioden i Cortus Energys företrädesemission inleds idag
June 30, 2021 02:15 ET
|
Cortus Energy AB
PRESSMEDDELANDE Stockholm, onsdagen den 30 juni 2021 Idag, den 30 juni 2021, inleds teckningsperioden i Cortus Energy AB:s (”Cortus Energy” eller ”Bolaget”)...
Transactions in connection with share buy-back programme
June 30, 2021 02:13 ET
|
H+H International A/S
On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the...
Changes in substantial shareholding
June 30, 2021 02:02 ET
|
Ekspress Grupp
AS Ekspress Grupp informs about the change in the structure of shareholders with substantial holdings. On 29 June 2021, an agreement was entered into, pursuant to which KJK Fund SICAV-SIF will...
Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
June 30, 2021 02:00 ET
|
Caledonia Mining Corporation
ST HELIER, Jersey, June 30, 2021 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN: CMCL; AIM: CMCL) announces that it received notification on June...
NORDIC ID OYJ:N YLIMÄÄRÄISEN YHTIÖKOKOUKSEN PÄÄTÖKSET 29. KESÄKUUTA 2021 JA HALLITUKSEN PUHEENJOHTAJAN VALINTA
June 30, 2021 02:00 ET
|
Nordic ID Oyj
NORDIC ID OYJ YHTIÖTIEDOTE 30.6.2020 KELLO 09.00 NORDIC ID OYJ:N YLIMÄÄRÄISEN YHTIÖKOKOUKSEN PÄÄTÖKSET 29. KESÄKUUTA 2021 JA HALLITUKSEN PUHEENJOHTAJAN VALINTA Nordic ID Oyj:n...
eQ has raised close to 700 million USD for North American Private Equity
June 30, 2021 02:00 ET
|
eQ Oyj
Press release30 June 2021, 09:00 am eQ Asset Management’s fourth US-focused private equity fund eQ PE XIII US has raised a record USD 293 million from the beginning of fund raising in January 2021....
Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of a T-Cell Priming Vaccine
June 30, 2021 02:00 ET
|
Emergex Vaccines Holding Ltd
PRESS RELEASE Emergex Receives Regulatory Approval for a Phase I Clinical Trial in Dengue of a T-Cell Priming Vaccine Swiss regulatory authorities, including the Swiss Agency for Therapeutic...
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670
June 30, 2021 02:00 ET
|
NMD Pharma
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 Aarhus, Denmark, 30 June 2021 – NMD Pharma A/S, a biotech company leading in the development...
Alliance Trust PLC - Board Changes
June 30, 2021 02:00 ET
|
Alliance Trust Plc
Alliance Trust PLC Board Changes Alliance Trust PLC hereby confirms, further to the announcement it made on 3 March 2021, that Karl Sternberg, the Company’s Senior Independent Director, is today...
Decreased number of shares and votes in Kinnevik
June 30, 2021 02:00 ET
|
Kinnevik
Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 June 2021 the total number of shares in the company amounts to 278,121,044, and the total number of votes in the company amounts to...
- September 26, 2024 21:32 ET Remee Wire & Cable Appoints John Orona as New Business Development Manager
- September 26, 2024 20:26 ET „LemON Tour” z Cytrynami z Syrakuz PGI przybywa na szczyt G7 ds. Rolnictwa